Other News to Note
Qrxpharma Ltd., of Sydney, said the FDA established May 25, 2014, as the new Prescription Drug User Fee Act date for action on the company’s refiled new drug application for immediate-release Moxduo, a version of hydrocodone and morphine. The FDA will schedule an advisory committee meeting prior to that date, and assuming approval, the company said it plans to launch the product in the U.S. in the second half of 2014.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter